Tefferi(Ayalew),Pardanani(Animesh) Int J Hematol 2004-07-20

...PDGFRB), which have been pathogenetically linked to clonal eosinophilia, and their presence predicts complete as well as...

Mao(Daniel Y L),Barsyte-Lovejoy(Dalia),Ho(... Nucleic Acids Res 2004-07-13

...PDGFRB). Using chromatin immunoprecipitation, we show that c-Myc binds to the proximal promoter of the PDGFRB gene in pr...

Morerio(Cristina),Acquila(Maura),Rosanda(C... Cancer Res 2004-06-10

...PDGFRB/HCMOGT-1 fusion. We show that the breakpoint of PDGFRB occurred at the same site of all previously reported PDGFR...

Vizmanos(José L),Novo(Francisco J),Román(J... Cancer Res 2004-06-10

We describe a new PDGFRB fusion associated with a t(5;14)(q33;q24) in a patient with a longstanding chronic myeloprolife...

Sutajová(Markéta),Neukirchen(Ursula),Meine... Genomics 2004-10-26

...PDGFRB, revealed no pathogenic mutations. Reevaluation of the clinical symptoms of the translocation patient challenges ...

Pardanani(Animesh),Tefferi(Ayalew) Blood 2004-11-04

...PDGFRB) tyrosine kinases. The drug has acquired therapeutic relevance because of similar inhibitory activity against cer...

Safley(Anne Michele),Sebastian(Siby),Colli... Genes Chromosomes Cancer 2004-05-25

...PDGFRB has been well established, to our knowledge there are only two previous reports describing a BCR-PDGFRA fusion ge...

Pardanani(Animesh),Tefferi(Ayalew) Leuk Res 2004-07-22

...PDGFRB gene that is located on chromosome 5q33. Furthermore, response to therapy has been rapid (within days) and durabl...

Wittman(Brenda),Horan(John),Baxter(Joanna)... Leuk Res 2004-07-22

...PDGFRB. Because the PDGFRB tyrosine kinase is one of the known targets of tyrosine kinase inhibitors, this patient achie...

Al-Ali(Haifa-Kathrin),Heinrich(Michael Cha... Hematol J 2004-09-30

...PDGFRB as possible causes of resistance in patients without ABL mutations.